Products
.png)
Taglipt Duo Film Coated Tablets
| Therapeutic Category | DPP-4 Inhibitor + SGLT2 Inhibitor (Antidiabetic) |
|---|---|
| Main Ingredient(s) | Sitagliptin + Ertugliflozin (5/100 mg, 15/100 mg) |
| Dosage Form | Film Coated Tablet |
| Description | Sitagliptin and ertugliflozin combination for type 2 diabetes. |
| Target Use / Indication | Type 2 Diabetes Mellitus |
| Key Benefits | Combines two complementary agents for blood glucose control. |